Structural insights into Staphylococcus aureus enoyl-ACP reductase (FabI), in complex with NADP and triclosan
about
Structure of theFrancisella tularensisenoyl-acyl carrier protein reductase (FabI) in complex with NAD+and triclosanMode of Action, In Vitro Activity, and In Vivo Efficacy of AFN-1252, a Selective Antistaphylococcal FabI InhibitorHigh-resolution structures ofThermus thermophilusenoyl-acyl carrier protein reductase in the apo form, in complex with NAD+and in complex with NAD+and triclosanStaphylococcus aureus FabI: Inhibition, Substrate Recognition, and Potential Implications for In Vivo EssentialityCrystal structures and kinetic properties of enoyl-acyl carrier protein reductase I fromCandidatus Liberibacter asiaticusRational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (ACP) Reductase InhibitorType II Fatty Acid Synthesis Is Essential for the Replication of Chlamydia trachomatisThe Halogen BondRational Modulation of the Induced-Fit Conformational Change for Slow-Onset Inhibition in Mycobacterium tuberculosis InhA.Discovery of a novel and potent class of F. tularensis enoyl-reductase (FabI) inhibitors by molecular shape and electrostatic matchingResistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI).Halogen bonding in halocarbon-protein complexes: a structural survey.Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 - 2010).Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents.Crystallization and preliminary X-ray crystallographic studies of enoyl-acyl carrier protein reductase (FabI) from Psuedomonas aeruginosa.Benzimidazole-Based FabI Inhibitors: A Promising Novel Scaffold for Anti-staphylococcal Drug Development.
P2860
Q27665567-7E4897C1-18A0-43DA-8800-924AC1D44A1EQ27671875-8DD1450C-82E7-496A-B54D-B283B7EF2977Q27673784-879851B7-2E61-452F-BDB5-D8A18B00884DQ27679034-EBEFC488-7438-4280-9D26-301D116284FAQ27681261-58B08D9F-A4FA-4B60-947E-952D46496D4DQ27683440-E950FD55-354A-4271-824C-17381D6507E2Q27684448-069936F0-8A9A-4A67-9CA4-2EE65F8B10B4Q28077775-7662D648-66BF-44CA-8A2C-0EFE7AB61E83Q34044404-44EA8CA5-188F-4F64-B0BF-3577AF7CFA13Q34078440-8FB5CD96-FE59-49E1-9239-0BB4609CCD6BQ37404976-40A44DD1-027A-4E16-8870-A563083645CEQ37848683-DA20A7A4-8884-4981-89F7-E46090D048A9Q37886187-E17ECED1-D76D-4437-95F5-7A9E79C25387Q38124842-5FFCEC27-7940-4F9E-BCC5-BA38B566C0B4Q38477356-98DB03F8-782A-48CF-B470-28A49860BD66Q39275601-148CA66B-1CC6-406A-8DA8-E2FF092DC781
P2860
Structural insights into Staphylococcus aureus enoyl-ACP reductase (FabI), in complex with NADP and triclosan
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Structural insights into Staph ...... omplex with NADP and triclosan
@ast
Structural insights into Staph ...... omplex with NADP and triclosan
@en
Structural insights into Staph ...... omplex with NADP and triclosan
@nl
type
label
Structural insights into Staph ...... omplex with NADP and triclosan
@ast
Structural insights into Staph ...... omplex with NADP and triclosan
@en
Structural insights into Staph ...... omplex with NADP and triclosan
@nl
prefLabel
Structural insights into Staph ...... omplex with NADP and triclosan
@ast
Structural insights into Staph ...... omplex with NADP and triclosan
@en
Structural insights into Staph ...... omplex with NADP and triclosan
@nl
P2093
P356
P1433
P1476
Structural insights into Staph ...... omplex with NADP and triclosan
@en
P2093
Amit Priyadarshi
Eunice Eunkyeong Kim
Kwang Yeon Hwang
P356
10.1002/PROT.22581
P407
P577
2010-02-01T00:00:00Z